Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Natasha M. Tiffany"'
Autor:
Ori Yellin, Donald Steven Colbourn, Benjamin Waterman, Albert T. Quiery, Kathryn H. Melamed, James O. Brady, H. K. Shamasunder, Ravi K. Patel, Siu Fun Wong, Natasha M. Tiffany, Eric Wirtschafter, James R. Berenson, Donald S. Gravenor
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 11:336-341
Background Monoclonal gammopathy of undetermined significance (MGUS) is a plasma cell proliferative disorder that transforms into multiple myeloma and other serious B-cell disorders at an approximate rate of 1% per year; these patients are also at in
Publikováno v:
Journal of Urology. 174:888-892
We determined the safety and preliminary efficacy of the combination of high dose pulse calcitriol (1,25-dihydroxycholecalciferol) with a standard regimen of docetaxel plus estramustine in patients with metastatic androgen independent prostate cancer
Autor:
Natasha M. Tiffany, William R. Woodward, Felix P. Eckenstein, Tracy E. Williams, Nicola J. Cherry, Charles K. Meshul
Publikováno v:
The Journal of Comparative Neurology. 370:147-158
Basic fibroblast growth factor (bFGF), a member of the heparin-binding growth factor family, is present in relatively high levels in the brain where it may play an important role in the maintenance, repair, and reorganization of the tissue. Although
Autor:
Nikola S. Lessov, Anthony L. McCall, William R. Woodward, Nicola J. Cherry, M. Thompson, Melissa Moholt-Siebert, A.M. Vanbueren, Hall Downes, Natasha M. Tiffany
Publikováno v:
Brain Research. 670:29-38
Brain damage after global forebrain ischemia is worsened by prior hyperglycemia and ameliorated by antecedent hypoglycemia. To assess whether GLUT3, the neuron specific glucose transporter and its mRNA, are affected by cerebral ischemia, we investiga
Autor:
Albert Shamouelian, Vanessa Bolejack, Regina A. Swift, Hank H. Yang, Gargi Upadhyaya, Adel Z. Makary, Shamel Sanani, Youram Nassir, Ashkan Sefaradi, Charles M. Farber, Harry Staszewski, Ori Yellin, Donald S. Gravenor, Neil Morganstein, James D. Hilger, James R. Berenson, John Crowley, Natasha M. Tiffany, Ian W. Flinn
Publikováno v:
American journal of hematology. 86(1)
Few studies have evaluated prognostic factors among patients with multiple myeloma (MM) since new therapies have become available. Monthly zoledronic acid (ZOL) has been incorporated into many treatment regimens to reduce skeletal-related events (SRE
Publikováno v:
Urology. 63(5)
Objectives. To determine the safety and efficacy of zoledronic acid (Zometa) combined with imatinib mesylate (Gleevec) in patients with bone pain due to androgen-independent prostate cancer. Methods. Fifteen patients were treated with zoledronic acid
Autor:
S Sanani, H Staszewski, H. L. Duvivier, N Morganstein, Regina A. Swift, A Shamouelian, Donald S. Gravenor, Ian W. Flinn, A. Makary, Charles M. Farber, Youram Nassir, Hank H. Yang, G. H. Upadhyaya, Ori Yellin, James R. Berenson, John Crowley, Natasha M. Tiffany, A Sefaradi
Publikováno v:
Clinical Lymphoma and Myeloma. 9:S12-S13
Autor:
Hank H. Yang, G. H. Upadhyaya, James R. Berenson, Ori Yellin, A. Makary, Donald Gravenor, Ian W. Flinn, John Crowley, Regina A. Swift, Natasha M. Tiffany, Harry Staszewski
Publikováno v:
Journal of Clinical Oncology. 27:e19519-e19519
e19519 Background: Although the overall survival of MM patients has improved with new treatment options, few studies have evaluated prognostic factors since these new therapies have become available. Monthly ZOL has been incorporated into many of the
Publikováno v:
Urology. 65:212
Publikováno v:
Journal of Clinical Oncology. 22:4678-4678
4678 Background: Phase II studies suggest that the clinical activity of docetaxel in AIPC may be increased by the addition of estramustine or high dose calcitriol. We sought to test the safety of a...